Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

DJ Irwin, VMY Lee, JQ Trojanowski - Nature Reviews Neuroscience, 2013 - nature.com
Dementia is increasingly being recognized in cases of Parkinson's disease (PD); such cases
are termed PD dementia (PDD). The spread of fibrillar α-synuclein (α-syn) pathology from …

Nonmotor features of Parkinson's disease subtypes

C Marras, KR Chaudhuri - Movement Disorders, 2016 - Wiley Online Library
Parkinson's disease is highly heterogeneous in early clinical features and later outcomes.
This makes classifying subgroups of PD relevant to clinical research and practice …

Premotor and nonmotor features of Parkinson's disease

JG Goldman, R Postuma - Current opinion in neurology, 2014 - journals.lww.com
Premotor and nonmotor features of Parkinson's disease : Current Opinion in Neurology
Premotor and nonmotor features of Parkinson's disease : Current Opinion in Neurology Log in or …

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease

JH Kang, DJ Irwin, AS Chen-Plotkin, A Siderowf… - JAMA …, 2013 - jamanetwork.com
Importance We observed a significant correlation between cerebrospinal fluid (CSF) levels
of tau proteins and α-synuclein, but not β-amyloid 1-42 (Aβ1-42), and lower concentration of …

Cerebrospinal fluid biomarkers in Parkinson disease

L Parnetti, A Castrioto, D Chiasserini… - Nature Reviews …, 2013 - nature.com
Clinical diagnosis of Parkinson disease (PD) is difficult in early stages of disease, with high
risk of misdiagnosis. The long preclinical phase of PD provides the possibility for early …

Amyloid-β and Parkinson's disease

EW Lim, D Aarsland, D Ffytche, RN Taddei… - Journal of …, 2019 - Springer
Parkinson's disease (PD) is the second commonest neurodegenerative disorder in the world
with a rising prevalence. The pathophysiology is multifactorial but aggregation of misfolded …

Evolution of Alzheimer's disease cerebrospinal fluid biomarkers in early Parkinson's disease

DJ Irwin, J Fedler, CS Coffey… - Annals of …, 2020 - Wiley Online Library
Objective We analyzed the longitudinal profile of Alzheimer's disease (AD) cerebrospinal
fluid (CSF) biomarkers in early Parkinson's disease (PD) compared with healthy controls …

Gait and balance in Parkinson's disease subtypes: objective measures and classification considerations

T Herman, A Weiss, M Brozgol, N Giladi… - Journal of …, 2014 - Springer
Parkinson's disease (PD) is often divided into tremor dominant (TD) and postural instability
gait difficulty (PIGD) subtypes. However, objective measures of gait (eg, stride length …

[HTML][HTML] Cognition and gait show a selective pattern of association dominated by phenotype in incident Parkinson's disease

S Lord, B Galna, S Coleman, A Yarnall… - Frontiers in aging …, 2014 - frontiersin.org
Reports outlining the association between gait and cognition in Parkinson's disease (PD)
are limited because of methodological issues and a bias toward studying advanced disease …

[HTML][HTML] Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease

FJ Jiménez-Jiménez, H Alonso-Navarro… - Frontiers in cellular …, 2014 - frontiersin.org
The blood-brain barrier supplies brain tissues with nutrients and filters certain compounds
from the brain back to the bloodstream. In several neurodegenerative diseases, including …